Covance MarketPlace Connects Biotech with Potential Partners - - BioPharm International

ADVERTISEMENT

Covance MarketPlace Connects Biotech with Potential Partners


Covance Inc. has introduced Covance MarketPlace, a solution that enables the company’s emerging biotechnology and established pharmaceutical clients to find and forge partnerships in a secure forum.

Covance MarketPlace connects the portfolios of biotechnology clients with select pharmaceutical partners looking for innovative molecules backed by high-quality and regulatory-compliant data, the company reports.

According to the company, Covance MarketPlace helps biotechnology companies more effectively showcase their molecules to larger pharmaceutical companies as they continue to increase their own in-licensing efforts.  With Covance conducting development work for all the molecules in Covance MarketPlace, prospective partners can be confident in the quality of the data, design of the plan and regulatory acceptance, the company reports.

Covance is working with its client base of more than 500 biotechnology companies to place their compounds into Covance MarketPlace.  Upon completion, Covance MarketPlace will be activated for select Covance pharmaceutical clients, giving them line-of-sight to molecules early in their development lifecycle, typically at the IND/CTA-enabling, first-in-human or proof-of- concept phase.

Source: Covance


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
Author Guidelines

Click here